Amedisys Inc financial data

Symbol
AMED on Nasdaq
Location
3854 American Way, Suite A, Baton Rouge, LA
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - Apr 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 122 % +20%
Debt-to-equity 82 % -8.03%
Return On Equity 7.48 %
Return On Assets 4.19 %
Operating Margin 4.48 % -30.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.8M shares +0.44%
Common Stock, Shares, Outstanding 32.8M shares +0.44%
Entity Public Float 3B USD +15.4%
Weighted Average Number of Shares Outstanding, Basic 32.8M shares +0.38%
Weighted Average Number of Shares Outstanding, Diluted 33.2M shares +0.73%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.37B USD +5.34%
General and Administrative Expense 856M USD +2.33%
Costs and Expenses 2.27B USD +7.58%
Operating Income (Loss) 106M USD -27%
Nonoperating Income (Expense) 43.9M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 150M USD +367%
Income Tax Expense (Benefit) 64.8M USD +21.4%
Net Income (Loss) Attributable to Parent 89.8M USD +324%
Earnings Per Share, Basic 3 USD/shares +323%
Earnings Per Share, Diluted 3 USD/shares +318%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 285M USD +163%
Accounts Receivable, after Allowance for Credit Loss, Current 320M USD -11.1%
Other Assets, Current 12M USD -53.8%
Assets, Current 634M USD +20.4%
Property, Plant and Equipment, Net 40.2M USD -5.85%
Operating Lease, Right-of-Use Asset 80.9M USD -8.5%
Intangible Assets, Net (Excluding Goodwill) 80.2M USD -21.2%
Goodwill 1.21B USD -2.47%
Other Assets, Noncurrent 135M USD +57.7%
Assets 2.18B USD +4.53%
Accounts Payable, Current 28.7M USD -20.8%
Employee-related Liabilities, Current 132M USD +0.07%
Accrued Liabilities, Current 162M USD +9.98%
Liabilities, Current 492M USD +1.48%
Long-term Debt and Lease Obligation 333M USD -6.5%
Deferred Income Tax Liabilities, Net 58M USD +34.2%
Operating Lease, Liability, Noncurrent 55.6M USD -10.6%
Other Liabilities, Noncurrent 848K USD +2.42%
Liabilities 940M USD -0.82%
Retained Earnings (Accumulated Deficit) 852M USD +11.8%
Stockholders' Equity Attributable to Parent 1.2B USD +10.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.25B USD +8.96%
Liabilities and Equity 2.18B USD +4.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.69M USD +43.6%
Net Cash Provided by (Used in) Financing Activities -13.3M USD -55.6%
Net Cash Provided by (Used in) Investing Activities -1.37M USD +55.2%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 38.4M shares +0.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 285M USD +136%
Interest Paid, Excluding Capitalized Interest, Operating Activities 6.18M USD -24.6%
Deferred Tax Assets, Valuation Allowance 5.2M USD -3.7%
Deferred Tax Assets, Gross 78M USD +2.09%
Operating Lease, Liability 82M USD -7.87%
Payments to Acquire Property, Plant, and Equipment 1.22M USD -54.5%
Lessee, Operating Lease, Liability, to be Paid 89.4M USD -7.65%
Property, Plant and Equipment, Gross 143M USD +6.56%
Operating Lease, Liability, Current 25.8M USD -1.67%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.8M USD -1.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 29.2M USD -1.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +23.8%
Deferred Income Tax Expense (Benefit) 9.98M USD +285%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.4M USD -5.13%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.5M USD -6.09%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.3M USD -14.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.79M USD +10.6%
Deferred Tax Assets, Net of Valuation Allowance 72.8M USD +2.54%
Interest Expense 32.3M USD +25.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%